Milestone Pharmaceuticals (MIST) Current Leases (2019 - 2026)
Milestone Pharmaceuticals' (MIST) quarterly Current Leases came in at $659000.0 in Q1 2026, up 21.59% YoY from $542000.0 in Q1 2025, and up 1.85% on a QoQ basis from $647000.0 in Q4 2025.
Milestone Pharmaceuticals (MIST) Current Leases (2019 - 2026) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 8 years of Current Leases data on file, last reported at $659000.0 in Q1 2026.
- Quarterly Current Leases rose 21.59% year-over-year to $659000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $659000.0 (up 21.59% YoY) and the FY2025 annual result came in at $647000.0, up 13.31% from the prior year.
- Current Leases rose to $659000.0 in Q1 2026, from $647000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $659000.0 in Q1 2026 to a low of $169000.0 in Q2 2022.
- A 5-year average of $504411.8 and a median of $530000.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases plunged 34.75% — and 2023, when it soared 208.88%.
- Tracing MIST's Current Leases over 5 years: stood at $495000.0 in 2022, then advanced by 10.3% to $546000.0 in 2023, then advanced by 4.58% to $571000.0 in 2024, then advanced by 13.31% to $647000.0 in 2025, then climbed by 1.85% to $659000.0 in 2026.
- The last three Current Leases figures came in at $659000.0 (Q1 2026), $647000.0 (Q4 2025), and $483000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - | 670,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 670,000.00 |
| Mar 31, 2026 | 659,000.00 |
| Dec 31, 2025 | 647,000.00 |
| Sep 30, 2025 | 483,000.00 |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 542,000.00 |
| Dec 31, 2024 | 571,000.00 |
| Sep 30, 2024 | 582,000.00 |
| Jun 30, 2024 | 567,000.00 |
| Mar 31, 2024 | 555,000.00 |
| Dec 31, 2023 | 546,000.00 |
| Sep 30, 2023 | 530,000.00 |
| Jun 30, 2023 | 522,000.00 |
| Mar 31, 2023 | 507,000.00 |
| Dec 31, 2022 | 495,000.00 |
| Sep 30, 2022 | 487,000.00 |
| Jun 30, 2022 | 169,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | 224,000.00 |
| Sep 30, 2021 | 254,000.00 |